Waiting
Traitement de la connexion…

Trial ends in Request Full Access Tell Your Colleague About Jove

CRISPR-Cas Synthetic Urine Biomarker Test for Cancer Diagnostics

December 8th, 2023
1, 1, 2, 2,3, 3,4, 2,3,4,5,6,7,8, 1,2,3
1Department of Biomedical Engineering, Boston University, 2Institute for Medical Engineering and Science, Massachusetts Institute of Technology, 3Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, 4Howard Hughes Medical Institute, 5Broad Institute of Massachusetts Institute of Technology and Harvard, 6Department of Electrical Engineering and Computer Science, Massachusetts Institute of Technology, 7Department of Electrical Engineering and Computer Science, Massachusetts Institute of Technology, 8Department of Medicine, Brigham and Women’s Hospital and Harvard Medical School

Summary
Automatic Translation

Questo protocollo descrive un test di biomarcatori urinari sintetici multianalita mediato da CRISPR-Cas che consente la diagnostica del cancro point-of-care attraverso l'analisi ex vivo delle attività della proteasi associata al tumore.

Article

Get cutting-edge science videos from JoVE sent straight to your inbox every month.

Waiting X
Simple Hit Counter